Sheri Vendemia

Sheri Vendemia serves as a key procurement professional within the Naval Medical Logistics Command, supporting the Department of Defense’s mission to sustain combat-ready medical forces through the acquisition of critical diagnostic and life-sustaining systems. She manages a portfolio of contracts focused on in-vitro diagnostic substances and advanced life sciences research and development, ensuring the Navy and Marine Corps maintain access to cutting-edge point-of-care technologies and clinical support tools. Her acquisitions directly enable frontline medical readiness, emphasizing rapid deployment, interoperability, and compliance with military medical standards across global operational environments. Vendemia works with a diverse range of vendors specializing in medical diagnostics, laboratory reagents, and biomedical R&D, including firms with expertise in FDA-regulated in-vitro diagnostic manufacturing and government-contracted life sciences innovation. While specific contractor names are not publicly disclosed, her procurement patterns reflect collaboration with both established medical technology suppliers and agile research-focused entities capable of meeting stringent DoD performance and supply chain resilience requirements. She maintains a results-driven contracting approach, prioritizing technical capability, regulatory compliance, and timely delivery over sole-source or sole-vendor dependencies. Vendemia’s contracting activity is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic preference for maximizing technical competition and access to the broadest possible industrial base, rather than socioeconomic set-asides. Her approach prioritizes mission-critical performance and supply chain robustness, aligning with the Naval Medical Logistics Command’s operational imperatives over socioeconomic contracting targets. Her primary procurement focus lies in NAICS 325413 for in-vitro diagnostic substance manufacturing and NAICS 541715 for physical and life sciences R&D. She consistently acquires specialized reagents, clinical assay kits, diagnostic platforms, and research-grade biomedical solutions critical to combat casualty care, infectious disease surveillance, and field-deployable diagnostics. Her domain expertise spans clinical laboratory systems, molecular diagnostics, and the transition of research prototypes into operational medical logistics pipelines.